August 2022 - With a large bipartisan majority, Congress passed, and the president signed the PACT-Act, a new law that expands VA health care and benefits to veterans exposed to toxic substances. Title V, provides funding for research.

​

Veterans live by the tenant, "Until they are home, no man left behind."  We believe this applies to the health of our surviving veterans.

​

Gosuranemab is an important component in the care plan for Parkinsonisms and has demonstrated some success.  We believe this may also have value for treatment and protection with other tauopathies.

​

We implore the VA and Biogen to "Act" now by starting production of, and clinical trials with Gosuranemab.